Stock info Novozymes | Filter  Basic-Info

Novozymes

The company's head quarter is located in Bagsvaerd. The company mostly operates in the chemical sector. Peder Holk Nielsen is the CEO of the company. Benny D. Loft leads the company as CFO. The global chemical companies gained around 72 percent over the period 2006-2016. Measured since 2011 the sector is 20 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 72 percent.

The past year was a good investment year for Novozymes investors

Over the period from December 2015 till December 2016 the stock lost around 26 percent. Over the period 2011-2016 the stock rose a massive 39,66 percent. Novozymes's revenues between 2011 and 2015 were relatively stable and moved between 2,76 billion euros and 3,34 billion euros. Novozymes's net incomes between 2011 and 2015 were very volatile and moved between 1,83 billion euros and 2,83 billion euros.

Novozymes paid out dividends in the past 5 years. Novozymes's dividend return over the period 2011 - 2015 was around 13,1 percent per year. Over the past 5 years Novozymes raised her dividends share each year. So we could call Novozymes a kind of dividend aristocrat.

At the end of 2015 around 6079 thousand people were on Novozymes' payroll.

Novozymes' balance mostly consists of equity

At the end of 2015 the Danish company's balance sheet was worth 17,79 billion euros. At the end of 2015 the total debt positon equaled 6,21 billion euros. This is around 34,91 percent of the total balance sheet. At the end of 2016 the Danish company was traded with a price/earnings-ratio of around 27. So investors paid 27 times the company's 2015's EPS. Based on the classical stock valuation theories the Danish stock can be seen as a value stock.

At the end of 2015 the chemical company's market capitalization (the number of shares times the market price) equaled around 101,88 billion euros. At the end of 2015 the Danish company had around 309,38 million stocks listed.

All the company's financial reports are available here. More information about Novozymes can be found it's website. .